Overall, these results confirmed the protective role of IDH against oxidative stress, and also suggested cell-permeable isocitrates as putative drug candidates for the treatment of DJ-1 deficiency-associated human pathology including PD (Fig 6). This evidence concerns the gene IDH1 and Parkinson disease.